
Aptinyx APTX
Quartalsbericht 2023-Q1
hinzugefügt 18.05.2023
Aptinyx EBITDA per Share 2011-2026 | APTX
EBITDA per Share Jährlich Aptinyx
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.92 | -1.1 | -1.07 | -1.76 | -2.69 | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -0.92 | -2.69 | -1.51 |
EBITDA per Share Vierteljährlich Aptinyx
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.3 | - | -0.21 | - | -0.29 | - | -0.31 | -0.29 | -0.21 | - | -0.24 | -0.27 | -0.34 | - | -0.45 | -0.38 | -0.52 | - | -0.44 | -1.85 | -2.18 | - | -1.54 | -1.54 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -0.21 | -2.18 | -0.668 |
EBITDA per Share anderer Aktien in der Pharmaeinzelhändler
| Name | EBITDA per Share | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
-15.2 | - | 2.43 % | $ 254 M | ||
|
AgeX Therapeutics
AGE
|
-2.35 | - | -10.17 % | $ 12.2 K | ||
|
BioNTech SE
BNTX
|
62.6 | $ 97.54 | -5.71 % | $ 27.2 B | ||
|
I-Mab
IMAB
|
0.08 | - | - | $ 866 M | ||
|
Akero Therapeutics
AKRO
|
-4.25 | - | - | $ 3.67 B | ||
|
Burford Capital Limited
BUR
|
1.11 | $ 5.2 | 5.69 % | $ 820 M | ||
|
Midatech Pharma plc
MTP
|
-0.09 | - | -18.52 % | $ 27.3 M | ||
|
AlloVir
ALVR
|
-3.02 | - | 4.14 % | $ 49.1 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
6.75 | - | - | $ 40.3 B | ||
|
Biophytis SA
BPTS
|
-0.23 | - | -13.47 % | $ 169 M | ||
|
Genfit SA
GNFT
|
-2.24 | - | 2.54 % | $ 160 B | ||
|
Cerus Corporation
CERS
|
-0.04 | $ 2.72 | 33.99 % | $ 518 M | ||
|
ACADIA Pharmaceuticals
ACAD
|
1.4 | $ 21.95 | -2.23 % | $ 3.64 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.22 | - | -1.52 % | $ 24.7 M | ||
|
Athira Pharma
ATHA
|
-23.7 | - | - | $ 269 M | ||
|
Applied Molecular Transport
AMTI
|
-3.2 | - | - | $ 10.1 M | ||
|
Ayala Pharmaceuticals
AYLA
|
-2.42 | - | - | $ 7.46 M | ||
|
AstraZeneca PLC
AZN
|
0.74 | - | - | $ 96.9 B | ||
|
Atreca
BCEL
|
0.14 | - | -11.76 % | $ 5.79 M | ||
|
Berkeley Lights
BLI
|
-1.29 | - | -7.31 % | $ 87 M | ||
|
Calithera Biosciences
CALA
|
-1.56 | - | -10.95 % | $ 876 K | ||
|
Advaxis
ADXS
|
-5.96 | - | -9.65 % | $ 45.9 M | ||
|
CymaBay Therapeutics
CBAY
|
-0.95 | - | - | $ 3.45 B | ||
|
ChemoCentryx
CCXI
|
-1.82 K | - | - | $ 3.74 B | ||
|
Институт стволовых клеток человека
ISKJ
|
-2.69 | - | - | - | ||
|
Cardiff Oncology
CRDF
|
-0.73 | $ 1.71 | -1.16 % | $ 114 M | ||
|
Caladrius Biosciences
CLBS
|
-2.67 | - | -16.75 % | $ 25.8 M | ||
|
Checkmate Pharmaceuticals
CMPI
|
-2.84 | - | - | $ 231 M | ||
|
Aeterna Zentaris
AEZS
|
-0.08 | - | 5.93 % | $ 314 M | ||
|
Brainstorm Cell Therapeutics
BCLI
|
-1.05 | - | -2.5 % | $ 5.88 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-6.7 | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-0.36 | - | - | $ 26.5 M | ||
|
Deciphera Pharmaceuticals
DCPH
|
-2.46 | - | - | $ 2.18 B | ||
|
AIkido Pharma
AIKI
|
-3.89 | - | 1.93 % | $ 17.4 M | ||
|
Editas Medicine
EDIT
|
-1.74 | $ 2.9 | -3.33 % | $ 257 M | ||
|
Dynavax Technologies Corporation
DVAX
|
-0.25 | - | - | $ 2.02 B | ||
|
Edesa Biotech
EDSA
|
-2.14 | $ 17.59 | -3.75 % | $ 56.2 M | ||
|
Akouos
AKUS
|
-2.45 | - | 0.23 % | $ 488 M | ||
|
Allakos
ALLK
|
-2.19 | - | - | $ 28.6 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-6.03 | $ 2.93 | -8.15 % | $ 4.82 M | ||
|
Eiger BioPharmaceuticals
EIGR
|
-48.4 | - | -9.21 % | $ 2.55 M | ||
|
Eloxx Pharmaceuticals
ELOX
|
-15.8 | - | -5.68 % | $ 8.28 M | ||
|
CureVac N.V.
CVAC
|
-2.22 | - | - | $ 867 M | ||
|
Ampio Pharmaceuticals
AMPE
|
0.15 | - | -11.43 % | $ 502 K | ||
|
Applied Therapeutics
APLT
|
-0.77 | - | - | $ 8.42 M | ||
|
Aptose Biosciences
APTO
|
0.01 | - | -45.71 % | $ 1.2 M | ||
|
Evogene Ltd.
EVGN
|
-0.77 | $ 0.81 | 3.33 % | $ 27.9 M | ||
|
Aravive
ARAV
|
-1.92 | - | -13.39 % | $ 1.45 M | ||
|
Aridis Pharmaceuticals
ARDS
|
-1.57 | - | 17.91 % | $ 11.1 M |